Journal of Labelled Compounds and Radiopharmaceuticals
译名:标记化合物与放射性药物杂志
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
1-3
2026
影响因子区间
—
平台估算
24%
2025
中国作者发文占比
—
收费
期刊简介:The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo.The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.
【译文】《标记化合物与放射性药物杂志》发表关于标记化合物制备及其应用的所有研究方面。这包括在体外和体内医学、药理学、生物学、生物化学和化学研究中使用的示踪方法。该杂志特别关注生物医学研究、放射性药物的诊断和治疗应用,涵盖了从基础代谢研究和技术开发到基于物理和化学特性明确的分子结构、配位化合物和纳米粒子的临床前和临床研究的所有发展阶段。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q4 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |